Sugammadex and Decreased Time to Extubation

What is the purpose of this trial?

The purpose of this study is to demonstrate faster time to extubation after arrival in the cardiothoracic intensive care unit (ICU) in patients undergoing isolated coronary artery bypass grafting (CABG) who receive Sugammadex as compared to placebo.


Participation Guidelines

Ages: 21 years and younger

Gender: Both


Merck Sharp & Dohme

Start Date: 09/18/2017

End Date: 12/31/2017

Last Updated: 02/22/2018

Study HIC#: 2000021124

Get Involved

For more information about this study, contact:
Karen B Stavris
+1 203-737-5037
karen.stavris@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image